- Home
- ZYXI vs EPIX Comparison
ZYXI vs EPIX Comparison
Compare ZYXI & EPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYXI
- EPIX
- Stock Information
- Founded
- ZYXI 1996
- EPIX 2009
- Country
- ZYXI United States
- EPIX Canada
- Employees
- ZYXI N/A
- EPIX N/A
- Industry
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- EPIX Biotechnology: Pharmaceutical Preparations
- Sector
- ZYXI Health Care
- EPIX Health Care
- Exchange
- ZYXI Nasdaq
- EPIX Nasdaq
- Market Cap
- ZYXI 72.3M
- EPIX 75.9M
- IPO Year
- ZYXI N/A
- EPIX N/A
- Fundamental
- Price
- ZYXI $1.64
- EPIX $0.24
- Analyst Decision
- ZYXI Hold
- EPIX Hold
- Analyst Count
- ZYXI 3
- EPIX 3
- Target Price
- ZYXI $3.00
- EPIX $2.00
- AVG Volume (30 Days)
- ZYXI 531.3K
- EPIX 13.5M
- Earning Date
- ZYXI 10-23-2025
- EPIX 08-13-2025
- Dividend Yield
- ZYXI N/A
- EPIX N/A
- EPS Growth
- ZYXI N/A
- EPIX N/A
- EPS
- ZYXI N/A
- EPIX N/A
- Revenue
- ZYXI $144,808,000.00
- EPIX N/A
- Revenue This Year
- ZYXI N/A
- EPIX N/A
- Revenue Next Year
- ZYXI $13.48
- EPIX N/A
- P/E Ratio
- ZYXI N/A
- EPIX N/A
- Revenue Growth
- ZYXI N/A
- EPIX N/A
- 52 Week Low
- ZYXI $1.23
- EPIX $0.22
- 52 Week High
- ZYXI $9.42
- EPIX $7.88
- Technical
- Relative Strength Index (RSI)
- ZYXI 45.22
- EPIX 5.39
- Support Level
- ZYXI $1.50
- EPIX $0.22
- Resistance Level
- ZYXI $1.75
- EPIX $1.94
- Average True Range (ATR)
- ZYXI 0.10
- EPIX 0.02
- MACD
- ZYXI 0.04
- EPIX -0.20
- Stochastic Oscillator
- ZYXI 81.58
- EPIX 0.86
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
About EPIX ESSA Pharma Inc.
ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.